Gov. Ron DeSantis called on the Biden administration to reverse its decision to revoke emergency use authorization (EUA) for Regeneron and Eli Lilly monoclonal antibody treatments.
“This abrupt and unilateral action by the Biden administration will prevent access to lifesaving treatments for Floridians and Americans,” insisted the governor’s office.
“Without a shred of clinical data to support this action, Biden has forced trained medical professionals to choose between treating their patients or breaking the law,” said DeSantis this week. “This indefensible edict takes treatment out of the hands of medical professionals and will cost some Americans their lives. There are real-world implications to Biden’s medical authoritarianism – Americans’ access to treatments is now subject to the whims of a failing president.”
“Rather than giving Americans the option for various COVID treatments, the FDA and the Biden Administration issued their royal decree, taking away the very thing that is proven to reduce hospitalizations and save lives,” said Lt. Gov. Jeanette Nuñez. “Monoclonal antibody treatments like Regeneron have had a positive impact for thousands of Floridians. For the CDC and FDA, which have been consistently inconsistent throughout the entire pandemic, to restrict treatment does nothing but put individuals at risk.”
“In our field of medicine, when someone comes to you seeking a treatment that could save their life, it is essential to have treatment options to ensure health care providers can make the best decisions for their patients,” said state Surgeon General Dr. Joseph Ladapo. “The Federal Government has failed to adequately provide the United States with adequate outpatient treatment options for COVID-19. Now, they are scrambling to cover up a failure to deliver on a promise to ‘shut down the virus.’”
“As a result of this abrupt and clinically unsupported action, the appointments for more than 2,000 Floridians to receive this treatment were canceled on January 25, 2022, alone. This decision was made solely by Biden’s Food and Drug Administration (FDA) without advance warning to states or health providers and without clinical data to support the decision. The deliberate decision by the Biden Administration to make this announcement effective immediately, through a press release, actively prevents states and health care providers from making real-time operational decisions that save lives,” the governor’s office noted. “Over the course of the past two years, scientists and researchers across the nation have worked hard to bring us treatments that are both safe and effective. One of these treatments has been monoclonal antibodies. This treatment has saved thousands of lives in Florida and across our nation.”
